A Prospective, 8-week, Multi-centre, Randomised, Open-label Clinical Investigation Comparing Clinical Efficacy and Safety of Berovenal® with a Reference Amorphous Hydrogel in Subjects with Shallow, Non-infected, Chronic Diabetic Foot Ulcer is a NA clinical asset sponsored by VULM s.r.o. in Diabetic Foot Ulcer. SEO and diligence focus: Berovenal®, NU-GEL Hydrogel with Alginate, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.